Gene Query: PSMD6

Dataset Description Geneva Score
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 145.03
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 145.03
RNA-Seq analysis of breast cancer cells after shikonin treatment 42.87
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 33.42
RNAseq of HEK293 cells after Chtop knockdown 29.41
Co-transcriptional loading of RNA export factors shapes the human transcriptome 29.41
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 26.28
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 26.28
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 24.96
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 24.23
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 23.62
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 23.23
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 22.89
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 21.47
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 19.47
Differential Gene Expression between MCF10A and MCF7 cells 16.77
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 16.51
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 16.45
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 16.18
snRNAs as regulators of alternative splicing 15.71
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 15.5
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 15.18
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 14.96
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 14.78
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 14.5
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 14.49
Crizotinib v. DMSO in SW480 cells 14.44
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 14.17
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 13.46
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 13.44
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 13.44
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 13.42
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 13.08
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 12.72
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 12.71
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 12.59
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 12.55
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 12.41
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 12.35
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 12.08
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 12.08
Differential expression of genes in AD169-infected MRC5. 12.03
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 12.01
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 11.97
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 11.86
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 11.86
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 11.5
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 11.5
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 11.38
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 11.38
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 11.37
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 11.32
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 11.27
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 11.27
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 10.9
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 10.81
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 10.74
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 10.59
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 10.5
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 10.39
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 10.28
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 10.27
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 10.27
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 10.26
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 10.25
Regulation of protein translation during mitosis 10.21
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 10.06
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 10.04
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 9.91
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 9.91
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 9.81
Comprehensive comparative analysis of 5’ end RNA sequencing methods 9.8
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 9.8
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 9.79
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 9.79
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 9.65
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 9.49
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 9.42
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 9.42
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 9.41
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 9.31
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 9.28
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 9.1
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 9.09
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 9.01
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 8.91
LncRNA-GAS5 negative regulation of YAP-target genes expression 8.73
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 8.7
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 8.69
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 8.69
Cell responses to dysregulated VZV-induced cell-cell fusion 8.66
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 8.66
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 8.62
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 8.55
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 8.37
Expression by CD133+ cells isolated from the adult human exocrine pancreas 8.36
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 8.33
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 8.26
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 8.26
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 8.24
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 8.22
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 8.21
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 8.21
Generation of KRAS signatures using immortalized isogenic lung cells. 8.19
Ribosomal footprinting of MDA-Parental and MDA-LM2 8.17
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 8.17
Identification of transcription start sites for human A549 cell line using ReCappable-seq 8.17
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 8.03
Lipid degradation promotes prostate cancer cell survival 8.02
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 8.02
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 7.9
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 7.85
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 7.85
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 7.65
HEK293 Heat-shock experiment 7.59
RNA-seq analysis of uveal melanoma cells treated with FR900359 7.56
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 7.5
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 7.5
CROP-Seq in Primary Human T Cells 7.48
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 7.42
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 7.41
MicroRNA targetome analysis during HCMV infection 7.41
Tracking distinct RNA populations using efficient and reversible covalent chemistry 7.39
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 7.29
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 7.28
RNA-seq melanoma 7.25
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 7.24
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 7.24
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 7.21
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 7.19
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 7.18
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 7.18
Next generation sequencing identifies discrete classes of box C/D snoRNAs featuring different ends and RNA binding protein dependency 7.17
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 7.15
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 7.13
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 7.13
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 7.13
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 7.13
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 7.11
Neonatal and adult human testis defined at the single-cell level 7.11
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 7.07
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 7.07
A transcriptome-wide divergence in protein translation scales with LIN28B expression 7.05
Expression level comparison under dividing and quiescent states in human primary fibroblasts 7.04
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 7.02
Control of prostate tumour growth by the long non-coding RNA GHSROS 7.02
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 6.8
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 6.79
Short and Long RNA sequencing of human mature erythrocytes 6.75
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 6.74
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 6.74
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 6.71
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 6.7
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 6.67
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 6.63
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 6.6
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 6.51
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 6.48
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 6.47
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 6.47
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 6.47
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 6.46
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 6.46
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 6.38
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 6.33
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 6.32
MYCi361 regulates MYC target genes 6.32
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 6.3
Aneuploidy-induced cellular stresses limit autophagic degradation. 6.29
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 6.26
Unique features and clinical importance of acute alloreactive immune responses 6.26
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 6.23
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 6.22
Transcriptome analysis upon C6orf203 silencing 6.19
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 6.18
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 6.15
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 6.14
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 6.14
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 6.12
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 6.12
Ribosomal footprinting of CN34-Parental and CN34-LM1a 6.12
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 6.11
MYC dependent mRNA translation shapes gene expression and cell biology 6.04
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 6.04
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 6.01
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 6.01
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 6.01
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 5.9
N6-methyladenine DNA Modification in Glioblastoma 5.9
Integrating single-cell transcriptomic data across different conditions, technologies, and species 5.86
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 5.86
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 5.81
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 5.8
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 5.7
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 5.69
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 5.66
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 5.65
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 5.64
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 5.63
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 5.63
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 5.59
Human cell line and subcutaneous tumor 5.58
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 5.56
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 5.54
The transcriptome and chromatin accessbility landscape of mammalian germline 5.54
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 5.45
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 5.43
RNA-Seq with and without RNase treatment in PCa cell lines 5.42
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 5.41
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 5.36
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 5.33
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 5.32
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 5.32
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 5.27
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 5.23
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 5.2
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 5.19
Gene expression changes associated with resistance to tagraxofusp (SL-401) 5.16
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 5.11
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 5.1
Novel Targeting of Transcription and Metabolism in Glioblastoma 5.1
SLIGRL-induced gene expression changes in NHEK cells 5.09
Total RNA-seq in ALL-SIL upon TLX1 knockdown 5.09
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 5.02
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 4.91
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 4.9
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 4.78
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 4.76
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 4.73
The DPYSL2 gene connects mTOR and schizophrenia 4.73
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 4.71
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 4.7
Differential Protein Occupancy Profiling of the mRNA Transcriptome 4.68
Transcription control by the ENL YEATS domain in acute leukemia 4.65
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 4.65
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 4.65
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 4.62
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 4.6
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 4.57
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 4.57
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 4.57
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 4.54
scRNASeq analysis of cycling cardiomyocytes 4.53
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 4.49
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 4.48
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 4.43
Ribosome profiling upon inhibition of eIF4A 4.37
Global Mapping of Human RNA-RNA Interactions 4.32
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 4.3
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 4.29
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 4.28
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 4.25
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 4.22
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 4.21
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 4.13
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 4.1
Effect of PRDM11 depletion in U2932 cells 4.1
An optimization system for isolating and sequencing of single human colon cancer cells 4.08
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 4.05
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 4.03
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 4.01
RNA-seq of RKO cells with cTAZ KO or putback 4.01
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 3.94
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 3.89
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 3.85
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 3.85
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 3.85
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 3.8
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 3.79
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 3.78
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 3.78
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 3.77
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 3.73
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 3.73
Identification of renal resident macrophages across species 3.61
MicroRNA-125a-5p overexpression in human macrophages 3.61
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 3.6
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 3.59
Measure transcript integrity using RNA-seq data 3.54
SLAM-seq for K562 endogenous mRNA decay 3.51
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 3.51
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 3.5
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 3.48
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 3.42
Cajal bodies are linked to genome conformation [RNA-Seq] 3.39
Cajal bodies are linked to genome conformation 3.39
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 3.38
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 3.36
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 3.35
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 3.34
Identification of a LIF-responsive replication-competent human β cell 3.34
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 3.33
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 3.33
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 3.33
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 3.32
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 3.32
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 3.31
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 3.27
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.27
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 3.24
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 3.24
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 3.24
RNA-sequencing of healthy human skeletal myocytes 3.22
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 3.2
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 3.19
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 3.17
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 3.13
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 3.13
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 3.11
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 3.03
An acquired vulnerability of drug resistant melanoma with therapeutic potential 2.97
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 2.97
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 2.96
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 2.9
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 2.88
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 2.87
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 2.84
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 2.84
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 2.8
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 2.78
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 2.78
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 2.76
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 2.72
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 2.7
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 2.69
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 2.69
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 2.63
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 2.63
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 2.63
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 2.6
Gene expression and genome-wide location analysis of breast cancer cell-lines 2.59
Gene expression analysis of breast cancer cell-lines 2.59
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 2.55
RNAseq of T-ALL upon long non coding rna purturbation 2.54
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 2.5
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 2.5
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 2.49
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 2.44
Iron response of HepG2 cells 2.43
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 2.38
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 2.37
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 2.37
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 2.37
FBXW7 modulates stress response by post-translational modification of HSF1 2.37
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 2.37
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 2.34
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 2.33
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.3
p53 activity results in DNA replication fork processivity 2.25
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 2.23
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 2.2
Real-time observation of light-controlled transcription in living cells 2.19
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 2.18
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.16
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 2.15
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 2.15
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 2.15
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 2.14
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 2.09
Biological effect of chronic mistranslation in mammalian cells 2.09
single cell RNA-seq from GM12878 (ENCSR673UIY) 2.07
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 2.06
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 2.06
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 2.06
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 2.05
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 2.05
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 2.03
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 2.02
Global response to chemotherapy-induced apoptosis 2.01
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 1.98
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 1.94
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 1.91
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 1.91
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 1.91
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  1.91
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.84
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 1.8
RNA-seq analysis of breast cancer 1.72
RNA-seq analysis and shRNA screen of breast cancer 1.72
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 1.71
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 1.7
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 1.65
Identification of renal resident macrophages across species [C1] 1.64
Transcriptional profiling of LS1034 cells treated with tepoxalin 1.63
O-glcnAc reprograms cellular energetics 1.61
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 1.61
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 1.58
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 1.57
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 1.56
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 1.56
Genome-wide Analysis of Chromatin Interactions in Human Cells 1.51
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.51
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 1.49
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 1.49
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 1.46
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.41
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 1.38
Myc activation coordinates gene transcription and protein translation responses 1.38
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 1.38
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.3
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 1.29
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 1.29
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 1.29
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.23
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.22
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 1.22
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 1.21
RNA seq with AML (NB4) cells upon FTO inhibition 1.17
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 1.14
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 1.13
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 1.11
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 1.07
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 1.04
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 1.04
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 1.03
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.02
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.92
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 0.91
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.88
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 0.88
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 0.88
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 0.85
4sUDRB-seq: measuring transcription elongation and initiation genomewide 0.85
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.84
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.84
RNA-seq data 0.8
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 0.79
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 0.76
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.75
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 0.75
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.74
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.74
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 0.72
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.7
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.69
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 0.69
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.67
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 0.67
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.63
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.63
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.63
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.63
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 0.61
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 0.61
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 0.59
Transcriptional landscape changes during human embryonic stem cell derivation 0.58
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 0.58
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.58
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 0.57
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.55
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.55
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.54
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 0.52
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 0.51
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 0.48
Modeling Human Cancer-induced Cachexia (Human) 0.47
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.45
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.45
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.45
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 0.43
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 0.43
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 0.39
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 0.39
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 0.37
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 0.37
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 0.35
Widespread regulated alternative splicing of single codons accelerates proteome evolution 0.34
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 0.33
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 0.33
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 0.33
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 0.33
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 0.33
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.33
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 0.33
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.29
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.28
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.27
Function and hormonal regulation of GATA3 in human first trimester placentation 0.26
Discovering human diabetes-risk gene function with genetics and physiological assays 0.25
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.24
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.21
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 0.17
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.16
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.11
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.1
Exogenous rescue of KLHL9 in SF210 cell line 0.09
Fusion discovery in breast cancer cell line 0.08
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.06
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.04
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.04
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 0.04
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.03
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 0.03
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.02
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.02
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.02
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 0.01
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 0.01
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.0
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation